Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter study of I10E in primary immunodeficiency
2010-023483-41Phase 2Completed
- Sponsor
- LFB Group
- Start
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of subcuvia in Immunogenetic disorder and common variable immunodeficiency (CVID), sponsored by LFB Group. Primary endpoint: Number of acute serious bacterial infections. Started Nov 2010; status: completed.
02
Drugs
subcuvia
03
Conditions
Immunogenetic disordercommon variable immunodeficiency (CVID)
Beyond the preview
Go deeper on 2010-023483-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023483-41.